SHR # 2306 :: RLRx :: New Guidelines on Male Hypogonadism Put Men At Greater Risk plus There's No Place for Zealotry in Prescribing HRT ::

SHR # 2306 :: RLRx :: New Guidelines on Male Hypogonadism Put Men At Greater Risk plus There's No Place for Zealotry in Prescribing HRT :: Adam Lamb - A paper published in February 2019 suggests that men not be treated for late onset hypogonadism until their total testosterone levels is 250ng/dL . This is very worrisome. Many physicians don't even want to prescribe testosterone due to its unfair demonization attracting more scrutiny from various licensure boards. PLUS There is no place in medicine for zealotry. Estradiol and Aromatase Inhibitors are not inherently good or bad. If you see people drawing a line in the sand claiming Aromatase Inhibitors are only good or only bad, run. ::